2 news items
Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
ABSI
21 Mar 24
capabilities, and expand our partnerships. These efforts reflect our commitment to innovation, promising better biologics for patients, faster
Latest Updates of Viva Biotech's Portfolio Companies
ABSI
6 Mar 24
cancer treatment candidate. It is reported that the agreement includes an upfront commitment, R&D funding and milestone payments, etc
- Prev
- 1
- Next